POSTMENOPAUSAL BLEEDING CLINICAL GUIDELINE; RISK AND INVESTIGATION PROSPECTIVE STUDYPOSTMENOPAUSAL BLEEDING CLINICAL GUIDELINE; RISK AND INVESTIGATION PROSPECTIVE STUDY
Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2019, Vol 8, Issue 8
Abstract
Postmenopausal uterine bleeding is defined as uterine bleeding after permanent cessation of menstruation resulting from loss of ovarian follicular activity. Bleeding can be spontaneous or related to ovarian hormone replacement therapy or to use of selective estrogen receptor modulators (eg, tamoxifen adjuvant therapy for breast carcinoma). Because anovulatory “cycles” with episodes of multimonth amenorrhea frequently precede menopause, no consensus exists regarding the appropriate interval of amenorrhea before an episode of bleeding that allows for the definition of postmenopausal bleeding. The clinician faces the possibility that an underlying malignancy exists, knowing that most often the bleeding comes from a benign source. Formerly, the gold-standard clinical investigation of postmenopausal uterine bleeding was institution-based dilation and curettage, but there now exist office-based methods for the evaluation of women with this complaint. Strategies designed to implement these diagnostic methods must be applied in a balanced way considering the resource utilization issues of overinvestigation and the risk of missing a malignancy with underinvestigation. Consequently, guidelines and recommendations were developed to consider these issues and the diverse spectrum of practitioners who evaluate women with postmenopausal bleeding. The guideline development group determined that, for initial management of spontaneous postmenopausal bleeding, primary asse sampling or transvaginal ultrasonography, allowing patients with an endometrial echo complex thickness of 4 mm or less to be managed expectantly. Guidelines are also provided for patients receiving selective estrogen receptor modulators or hormone replacement therapy, and for an endometrial echo complex with findings consistent with fluid in the endometrial cavity.ssment may be with either endometrial.
Authors and Affiliations
Dr. Liqaa Shaher Saleh
Keywords
Related Articles
- EP ID EP669048
- DOI -
- Views 116
- Downloads 0
SOLID WASTE MANAGEMENT: A CHALLENGE TO OUR SOCIETYCASE STUDY JHANSI, UTTAR PRADESH
The waste has potential to pose threat to land air and soil. The poor solid waste management leads to social, economic, health and environmental problems. Jhansi is famous for being tourist city of the UP state. The prob...
ANTIFUNGAL ACTIVITIES OF SOME EXTRACTS OF STREPTOGYNA CRINITA ON IN VITRO GROWTH OF CANDIDA ALBICANS, CANDIDA TROPICALIS, CRYPTOCOCCUS NEOFORMANS AND ASPERGILLUS NIGER
Mycoses establish one of the infectious pathologies furthermore in pus emergent especially because of its eukaryotic cellstructure.Thus he turns out to be necessary to solve this health problem by other medicinal alterna...
CHRONIC MYELOID LEUKEMIA PATIENT WITH ISOLATED CENTRAL NERVOUS SYSTEM BLAST CRISIS
The first therapeutic choice in Chronic Myeloid Leukemia (CML) is imatinib mesylate, a potent inhibitor of BCR / ABL tyrosine kinase. The blood brain barrier is poorly penetrated so that therapeutic concentrations in the...
FORMULATION DEVELOPMENT AND EVALUATION OF SKIN CARE EMULGEL FROM NATURAL OILS
This study was aimed to formulate Linseed oil loaded Emulsion (o/w) based gels, by using various concentrations of rose oil and lemon oil as penetration enhancers for transdermal drug delivery. By using response surface...
EXTRACTION, ELUCIDATION, CHARACTERIZATION AND EVALUATION OF ANTIBACTERIAL ACTIVITY OF FOUR PURE COMPOUND FROM BARRINGTONIA RACEMOSA LEAF EXTRACT
Objective: This study involves the extraction, isolation and characterization of chemical constituent from Barringtonia racemosa leaf extract. Methods: the dried leaves of Barringtonia racemosa was subjected to sequentia...